You are here: Industry Insights > antibody

News List

Biogen, Vir Enter COVID-19 Antibody Alliance contractpharma
March 16, 2020
Biogen will provide cell line development, process development and clinical manufacturing for Vir's monoclonal antibodies.
Mutations in plasma cells play a key role in light-chain amyloidosis expresspharma
March 12, 2020
The team of scientists succeeded in identifying eleven mutations caused by the disease in the antibodies of a patient with advanced AL amyloidosis.
Drug delivery method leads to sustained HIV antibody production in study europeanpharmaceuticalreview
March 11, 2020
Using AAV-based technology to deliver mAbs in a Phase I trial, researchers report that participants successfully developed antibodies against HIV.
Samsung Biologics, STCube Ink Cancer Drug Deal contractpharma
March 09, 2020
Enter into development and manufacturing agreement for novel target anticancer drug.
Absolute Antibody Launches FleXpress contractpharma
March 06, 2020
High-throughput recombinant antibody production service enables rapid production of large numbers of recombinant antibodies at 80 ml scale.
Antibody Production Successfully Induced in the First Batch of Vaccines fmprc
February 25, 2020
Song Zhiheng, deputy head of the Science and Technology Department of Zhejiang Province, said that the first batch of vaccines has successfully induced antibody production and entered the stage of animal test.
Roche HER2-ADC Enmetrastuzumab has been approved for marketing in China En-CPhI.CN
January 19, 2020
Detailed story will be updated soon, please stay tuned with us.
Important Progresses of New Drugs Marketed in China in 2019 En-CPhI.CN
January 07, 2020
Imported Drugs:1、Novartis CTL019 Applied for Clinical Trial in China to Officially Enter the Chinese Market Novartis f
FDA Approves New Drug, PADCEV to Treat Locally Advanced or Metastatic Urothelial Cancer Lin Zhang
January 03, 2020
A new drug, PADCEV (enfortumab vedotin-ejfv) to treat patients with locally advanced or metastatic urothelial cancer, was approved under the FDA’s Accelerated Approval Program based on tumor response rate.
Genmab, CureVac Enter Partnership to Develop mRNA-based Antibody Therapeutics americanpharmaceuticalreview
December 23, 2019
Genmab and CureVac have entered into a research collaboration and license agreement. This strategic partnership will focus on the research and development of ...